What Is GHRP-6?
GHRP-6 (Growth Hormone Releasing Peptide-6) is classified as a ghrp peptide. Synthetic hexapeptide that stimulates GH release by acting on the ghrelin/GHS receptor (GHSR1a) in the pituitary and hypothalamus. Unlike Ipamorelin, GHRP-6 is non-selective and also stimulates appetite (via ghrelin mimicry), raises cortisol and prolactin modestly, and has notable gastric motility effects. One of the earliest and most well-studied GH secretagogues.
It is extensively evaluated in laboratory and clinical settings for its potential to drive potent gh release, appetite stimulation, muscle growth, recovery, gastric motility. Researchers target GHRP-6 for its ability to interact with specific cellular and molecular pathways, making it a compound of significant interest across multiple therapeutic domains.
Well-studied but less selective than Ipamorelin. Raises cortisol (~15-20% transient) and prolactin modestly. Strong appetite stimulation can be a benefit (cachexia) or side effect (body composition goals). Not FDA-approved.
How Does GHRP-6 Work?
Synthetic hexapeptide that stimulates GH release by acting on the ghrelin/GHS receptor (GHSR1a) in the pituitary and hypothalamus. Unlike Ipamorelin, GHRP-6 is non-selective and also stimulates appetite (via ghrelin mimicry), raises cortisol and prolactin modestly, and has notable gastric motility effects. One of the earliest and most well-studied GH secretagogues.
At the molecular level, GHRP-6 operates through pathways characteristic of the GHRP class. By interacting with target receptors and downstream signaling cascades, the compound initiates biological responses associated with potent gh release, appetite stimulation, muscle growth, recovery, gastric motility.
Expected Research Timeline
Weeks 2–4
Elevated GH confirmed on bloodwork; faster recovery; early lean mass shifts
Months 2–3
Measurable body composition improvement; sustained appetite increase; IGF-1 elevation
Long-Term
Continued GH axis support; may develop mild tachyphylaxis requiring cycling
What Does the Research Say?
The following are key findings from peer-reviewed studies on GHRP-6, indexed on PubMed and equivalent databases:
[1]GHRP-6 dose-dependent GH release in humans
Bowers et al. (Endocrine Reviews): Comprehensive characterization of GHRP-6 showing dose-dependent GH release in humans with peak response at 1-2mcg/kg IV. Established GHRP-6 as the prototype GH secretagogue.
Evidence: moderate[2]GHRP-6 synergy with GHRH for amplified GH release
Combined GHRP-6 + GHRH produces synergistic GH release 3-5x greater than either peptide alone, demonstrating distinct receptor mechanisms.
Evidence: moderate[3]GHRP-6 cardioprotective effects in ischemia models
Berlanga et al.: GHRP-6 demonstrates significant cardioprotective effects in myocardial ischemia-reperfusion injury models, reducing infarct size and oxidative damage independent of GH release.
Evidence: preclinical[4]GHRP-6 stimulates gastric motility and appetite
Study confirms GHRP-6 activates ghrelin receptors in the GI tract, increasing gastric emptying rate and appetite. Clinically relevant for cachexia/wasting conditions.
Evidence: moderateSafety & Side Effects
Well-studied but less selective than Ipamorelin. Raises cortisol (~15-20% transient) and prolactin modestly. Strong appetite stimulation can be a benefit (cachexia) or side effect (body composition goals). Not FDA-approved.
| Side Effect | Incidence | Severity |
|---|---|---|
| Intense hunger / appetite surge | ~60-80% of users | moderate |
| Water retention | ~20% of users | mild |
| Cortisol elevation (transient) | ~15% of users | mild |
| Tingling / numbness | ~8% of users | mild |
| Headache | ~5% of users | mild |
FDA Status: Not Approved for Human Therapeutic Use
GHRP-6 is not currently FDA-approved for human use. It is available for research purposes only. Always consult a licensed healthcare provider.
How Is GHRP-6 Used?
Route
SubQ
Dose Range
100–300 mcg
Frequency
1-3x daily
Cycle
8–16 wk
Timing: Pre-bed, morning fasted, or pre-meal
Notes: Standard research dose: 100-300mcg per injection. Must be taken on empty stomach (food blunts GH release by ~75%). Appetite surge hits within 20-30 minutes of injection.
All dosing information reflects parameters reported in published research literature and is not intended as clinical guidance. Usage of any peptide should be supervised by a qualified healthcare professional.
GHRP-6 vs. Related Compounds
| Compound | Primary Use |
|---|---|
| GHRP-6(this page) | Potent GH release, appetite stimulation, muscle growth, recovery, gastric motility |
| CJC-1295 | Muscle growth, fat loss, recovery |
| GHRP-2 | Strongest GH release of standard GHRPs, muscle growth, anti-aging, recovery |
| Hexarelin | Most potent GH release of any GHRP, cardioprotection, muscle growth, recovery |
Where to Source GHRP-6 for Research
Purchasing ultra-high purity, laboratory-grade peptides is critical for verifiable research. We only recommend vendors providing independent, third-party HPLC Certificates of Analysis (COA).
Disclosure: PeptiDex may earn a commission from purchases. This does not affect our recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Frequently Asked Questions
What is GHRP-6?
GHRP-6 is a ghrp peptide. Synthetic hexapeptide that stimulates GH release by acting on the ghrelin/GHS receptor (GHSR1a) in the pituitary and hypothalamus. Unlike Ipamorelin, GHRP-6 is non-selective and also stimulates appetite (via ghrelin mimicry), raises cortisol and prolactin modestly, and has notable gastric motility effects. One of the earliest and most well-studied GH secretagogues.
What are the primary research benefits of GHRP-6?
Published research identifies primary mechanisms targeting: Potent GH release, appetite stimulation, muscle growth, recovery, gastric motility. These findings come from 4+ peer-reviewed studies indexed in our database.
What is the half-life of GHRP-6?
In published pharmacokinetic data, GHRP-6 demonstrates a half-life of approximately 2.5 hours.
Is GHRP-6 FDA approved?
GHRP-6 is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is studied under investigational protocols. Always consult a healthcare provider.
What are common side effects of GHRP-6?
Reported side effects in published literature include Intense hunger / appetite surge (~60-80% of users), Water retention (~20% of users), Cortisol elevation (transient) (~15% of users), Tingling / numbness (~8% of users), Headache (~5% of users). Most are classified as moderate in severity.
How is GHRP-6 administered?
In research settings, GHRP-6 is typically administered via SubQ. Standard research dose: 100-300mcg per injection. Must be taken on empty stomach (food blunts GH release by ~75%). Appetite surge hits within 20-30 minutes of injection.
Sources
- GHRP-6 dose-dependent GH release in humans. View on PubMed
- GHRP-6 synergy with GHRH for amplified GH release. View on PubMed
- GHRP-6 cardioprotective effects in ischemia models. View on PubMed
- GHRP-6 stimulates gastric motility and appetite. View on PubMed